Best Researcher Award
Defeng Xu
Changzhou University, China
Defeng Xu is a distinguished professor, doctoral advisor, research director, and innovation leader affiliated with Changzhou University, China. His multidisciplinary work spans pharmaceutical sciences, medicinal chemistry, nanomedicine, sustainable technology, agrochemical innovation, and translational research. Through academic leadership, industrial collaboration, patent development, and research commercialization, he has contributed substantially to scientific advancement and talent cultivation within chemical engineering and pharmaceutical research communities.[1]
Abstract
This article summarizes the academic achievements, research leadership, innovation activities, publication record, and professional recognition of Defeng Xu. His work integrates pharmaceutical engineering, medicinal chemistry, targeted drug delivery, traditional medicine modernization, and sustainable industrial technologies. The profile highlights measurable scholarly impact, technology transfer accomplishments, and educational contributions relevant to consideration for academic distinction and researcher recognition awards.[1]
Keywords
Pharmaceutical Engineering; Medicinal Chemistry; Drug Discovery; Nanomedicine; Targeted Drug Delivery; Chemical Engineering; Sustainable Technology; Traditional Chinese Medicine; Technology Commercialization; Research Leadership.
Introduction
Defeng Xu serves as Professor and Doctoral Advisor at the School of Pharmacy, Changzhou University, and Director of the Yangtze River Delta Emerging Industries Technology Cooperation Research Center. His career encompasses industrial engineering, academic research, corporate leadership, and international collaboration. Research activities have focused on novel therapeutics, anti-cancer mechanisms, bioactive compounds, agricultural resource utilization, and innovative green technologies that support both scientific advancement and societal development.[1]
Research Profile
Defeng Xu earned a Ph.D. in Medicinal Chemistry from Shanghai Jiao Tong University and subsequently developed a career spanning research institutes, universities, industry, and international academic environments. His expertise includes targeted nanotherapy, synthetic biology, medicinal chemistry, natural products research, functional foods, green chemistry, and agrochemical innovation. He has directed numerous funded projects, supervised postgraduate researchers, and established collaborations linking Chinese and international institutions through research and technology development initiatives.[2]
Research Contributions
Research contributions include development of anti-androgen receptor therapies, advanced prostate cancer treatment strategies, targeted nanoformulations, natural product valorization, and high-value utilization of agricultural resources. He has led more than thirty national and provincial projects, secured competitive research funding, and supported technology commercialization. Contributions also extend to innovation education, entrepreneurship training, interdisciplinary research management, and establishment of industry–academia collaboration frameworks.[3]
-
Novel anti-cancer drug discovery and development, Targeted drug delivery and nanomedicine systems, Traditional Chinese medicine quality research, Agricultural waste resource utilization technologies, Research commercialization and patent translation.
Publications
Defeng Xu has authored more than 150 scholarly publications, including over 100+ SCI-indexed articles, with research appearing in internationally recognized journals. Recent studies address pharmaceutical engineering education, cancer nanotherapy, drug conjugates, androgen receptor-targeting compounds, and asymmetric synthesis. These publications demonstrate sustained scholarly productivity and engagement with contemporary scientific challenges across medicinal chemistry and pharmaceutical sciences.[1][3][4][5]
Research Impact
According to Scopus metrics, the researcher has accumulated 1,833 citations across 114 indexed documents and achieved an h-index of 22. Additional impact is reflected through 46 authorized invention patents, international patent activity, technology industrialization outcomes, competitive grant acquisition, graduate supervision, and recognition from scientific organizations. Student innovation teams under his guidance have received national and provincial awards, further demonstrating educational influence and research leadership.[1]
Award Suitability
The academic record of Defeng Xu reflects a combination of research productivity, innovation leadership, educational excellence, technology transfer achievements, patent generation, grant acquisition, and professional service. Honors such as the Hou Debang Chemical Science and Technology Innovation Award, Science and Technology Achievement Award, National Commercial Science and Technology Innovation Figure recognition, and multiple provincial talent distinctions indicate broad acknowledgment of his contributions. These documented accomplishments align with common evaluation criteria associated with major academic researcher recognition programs and Best Researcher Award considerations.[2]
Conclusion
Defeng Xu has established a multidisciplinary research portfolio integrating pharmaceutical sciences, chemical engineering, innovation management, and technology commercialization. Through scholarly publications, patents, funded projects, educational leadership, and international collaboration, he has contributed to scientific knowledge and practical technological advancement. Available evidence demonstrates sustained academic impact, making his profile notable within the fields of pharmaceutical and chemical research.[1]
External Links
References
- Elsevier. (n.d.). Scopus author details: Defeng Xu, Author ID 7404073703. Scopus. https://www.scopus.com/authid/detail.uri?authorId=7404073703
- ORCID. (n.d.). Defeng Xu ORCID record. https://orcid.org/0000-0003-0506-1876
- Xu, D., Hu, H., Liang, J., Wang, Y., Ma, X., & Ni, Y. (2026). Theoretical research and practical exploration of a new model for cultivating top pharmaceutical engineering talent in the new era. Industry and Higher Education. DOI: https://doi.org/10.1177/09504222261452707
- Zhang, B., Deng, Y., Xu, D., & Zhao, X. (2025). Dimethylcurcumin and copper sulfate-loaded silk nanoparticles for synergistic therapy against breast cancer. ACS Biomaterials Science & Engineering. DOI: https://doi.org/10.1021/acsbiomaterials.4c02389
- Li, Q., Liu, Y., Cheng, Y., Cao, H., Du, K., Zhu, T., Xu, D., & Hu, H. (2025). Reduction-responsive RGD-docetaxel conjugate: Synthesis, in vitro drug release and in vitro antitumor activity. Drug Development Research. DOI: https://doi.org/10.1002/ddr.70043